Table IV.
AMH, testosterone, androstatien and DAHE-S as mean±SD, stratified by outcome of IVF/ICSI in PCOS women
|
Obese PCOS (n=91)
|
Over-weight PCOS (n=104)
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| IVF/ICSI outcome |
AMH
(ng/ml) |
TT
(nmol/L) |
A4
(nmol/L) |
DAHE-S
(µ mol/L) |
AMH
(ng/ml) |
TT
(nmol/L) |
A4
(nmol/L) |
DAHE-S
(µ mol/L) |
|
| Embryo quality | |||||||||
| Good | 3.4 ± 0.3 a | 0.3 ± 0.1 a | 3.9 ± 1.6 a | 3.5 ± 0.3 a | 3.8 ± 0.01 a | 0.3 ± 0.1 a | 2.25 ± 0.78 a | 2.7 ± 1 a | |
| Moderate | 3.8 ± 0.4 | 0.17 ± 0.12 | 5.8 ± 4.8 | 4.2 ± 2 | 3 ± 0.5 | 0.18 ± 0.09 | 2.81 ± 0.82 | 5.2 ± 2 | |
| Bad | 4.1 ± 0.3 | 0.13 ± 0.04 | 2.2 ± 1 | 2.4 ± 1 | 3.6 ± 0.6 | 0.15 ± 0.07 | 3.25 ± 0.56 | 4.6 ± 1.7 | |
| Chemical pregnancy | |||||||||
| Non-pregnant (n= 65) | 4.2 ± 0.5 a | 0.14 ± 0.05 | 3.7 ± 2.1 | 3.1 ± 1.8 | 3.2 ± 0.9 | 0.24 ± 0.1 a | 3.1 ± 0.8 a | 4.3 ± 1.7 | |
| Pregnant (n=130) | 3.7 ± 0.3 | 0.2 ± 0.02 | 4.4 ± 4 | 3.5 ± 1.7 | 3.5 ± 0.2 | 0.16 ± 0.09 | 2.7 ± 0.7 | 4.8 ± 2 | |
| Clinical pregnancy | |||||||||
| Non-pregnant (n= 79) | 4.1 ± 0.5 a | 0.13 ± 0.05 a | 3.7 ± 1.8 | 3 ± 1.6 a | 3.3 ±0.9 | 0.23 ± 0.13 a | 3.2 ± 0.78 a | 4.5 ± 1.6 | |
| Pregnant (n=116) | 3.6 ± 0.3 | 0.22 ± 0.02 | 4.5 ± 4 | 3.7 ± 1.7 | 3.4 ± 0.3 | 0.17 ± 0.1 | 2.7 ± 0.8 | 4.8 ± 2 | |
Statistical analysis using analysis of variance (ANOVA),
a
significant at p˂0.01.